Ropes & Gray represented Viridian Therapeutics, Inc. in the offering, and Wilmer Cutler Pickering Hale and Dorr represented the underwriters.Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology…
Viridian Therapeutics’ $258.8 Million Follow-on Public Offering
